Data from the largest ever real-world clinical analysis of over 700k peripheral arterial and peripheral venous patients on lower extremity peripheral intervention for IVUS, demonstrate a 27% reduction in risk for major adverse limb events (MALE), including acute limb ischemia or major amputation.